IBDEI16E ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,19079,1,4,0)
;;=4^F17.291
;;^UTILITY(U,$J,358.3,19079,2)
;;=^5003376
;;^UTILITY(U,$J,358.3,19080,0)
;;=F17.290^^64^848^11
;;^UTILITY(U,$J,358.3,19080,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19080,1,3,0)
;;=3^Nicotine Dependence,Oth Tobacco Product,Uncomplicated
;;^UTILITY(U,$J,358.3,19080,1,4,0)
;;=4^F17.290
;;^UTILITY(U,$J,358.3,19080,2)
;;=^5003375
;;^UTILITY(U,$J,358.3,19081,0)
;;=F17.201^^64^848^12
;;^UTILITY(U,$J,358.3,19081,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19081,1,3,0)
;;=3^Nicotine Dependence,Unspec,In Remission
;;^UTILITY(U,$J,358.3,19081,1,4,0)
;;=4^F17.201
;;^UTILITY(U,$J,358.3,19081,2)
;;=^5003361
;;^UTILITY(U,$J,358.3,19082,0)
;;=F17.200^^64^848^13
;;^UTILITY(U,$J,358.3,19082,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19082,1,3,0)
;;=3^Nicotine Dependence,Unspec,Uncomplicated
;;^UTILITY(U,$J,358.3,19082,1,4,0)
;;=4^F17.200
;;^UTILITY(U,$J,358.3,19082,2)
;;=^5003360
;;^UTILITY(U,$J,358.3,19083,0)
;;=F19.20^^64^848^17
;;^UTILITY(U,$J,358.3,19083,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19083,1,3,0)
;;=3^Psycoactive Substance Dependence,Uncomplicated
;;^UTILITY(U,$J,358.3,19083,1,4,0)
;;=4^F19.20
;;^UTILITY(U,$J,358.3,19083,2)
;;=^5003431
;;^UTILITY(U,$J,358.3,19084,0)
;;=F43.11^^64^848^14
;;^UTILITY(U,$J,358.3,19084,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19084,1,3,0)
;;=3^PTSD,Acute
;;^UTILITY(U,$J,358.3,19084,1,4,0)
;;=4^F43.11
;;^UTILITY(U,$J,358.3,19084,2)
;;=^5003571
;;^UTILITY(U,$J,358.3,19085,0)
;;=F43.12^^64^848^15
;;^UTILITY(U,$J,358.3,19085,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19085,1,3,0)
;;=3^PTSD,Chronic
;;^UTILITY(U,$J,358.3,19085,1,4,0)
;;=4^F43.12
;;^UTILITY(U,$J,358.3,19085,2)
;;=^5003572
;;^UTILITY(U,$J,358.3,19086,0)
;;=F43.10^^64^848^16
;;^UTILITY(U,$J,358.3,19086,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19086,1,3,0)
;;=3^PTSD,Unspec
;;^UTILITY(U,$J,358.3,19086,1,4,0)
;;=4^F43.10
;;^UTILITY(U,$J,358.3,19086,2)
;;=^5003570
;;^UTILITY(U,$J,358.3,19087,0)
;;=Z87.891^^64^848^4
;;^UTILITY(U,$J,358.3,19087,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19087,1,3,0)
;;=3^Hx of Nicotine Dependence
;;^UTILITY(U,$J,358.3,19087,1,4,0)
;;=4^Z87.891
;;^UTILITY(U,$J,358.3,19087,2)
;;=^5063518
;;^UTILITY(U,$J,358.3,19088,0)
;;=F32.A^^64^848^3
;;^UTILITY(U,$J,358.3,19088,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19088,1,3,0)
;;=3^Depression,Unspec
;;^UTILITY(U,$J,358.3,19088,1,4,0)
;;=4^F32.A
;;^UTILITY(U,$J,358.3,19088,2)
;;=^5161153
;;^UTILITY(U,$J,358.3,19089,0)
;;=L40.2^^64^849^1
;;^UTILITY(U,$J,358.3,19089,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19089,1,3,0)
;;=3^Acrodermatitis Continua
;;^UTILITY(U,$J,358.3,19089,1,4,0)
;;=4^L40.2
;;^UTILITY(U,$J,358.3,19089,2)
;;=^5009162
;;^UTILITY(U,$J,358.3,19090,0)
;;=L03.91^^64^849^2
;;^UTILITY(U,$J,358.3,19090,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19090,1,3,0)
;;=3^Acute Lymphangitis,Unspec
;;^UTILITY(U,$J,358.3,19090,1,4,0)
;;=4^L03.91
;;^UTILITY(U,$J,358.3,19090,2)
;;=^5009068
;;^UTILITY(U,$J,358.3,19091,0)
;;=L23.9^^64^849^3
;;^UTILITY(U,$J,358.3,19091,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19091,1,3,0)
;;=3^Allergic Contact Dermatitis
;;^UTILITY(U,$J,358.3,19091,1,4,0)
;;=4^L23.9
;;^UTILITY(U,$J,358.3,19091,2)
;;=^5009125
;;^UTILITY(U,$J,358.3,19092,0)
;;=L03.90^^64^849^4
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI16E 3771 printed Apr 09, 2024@21:40:29 Page 2
IBDEI16E ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,19079,1,4,0)
+2 ;;=4^F17.291
+3 ;;^UTILITY(U,$J,358.3,19079,2)
+4 ;;=^5003376
+5 ;;^UTILITY(U,$J,358.3,19080,0)
+6 ;;=F17.290^^64^848^11
+7 ;;^UTILITY(U,$J,358.3,19080,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,19080,1,3,0)
+10 ;;=3^Nicotine Dependence,Oth Tobacco Product,Uncomplicated
+11 ;;^UTILITY(U,$J,358.3,19080,1,4,0)
+12 ;;=4^F17.290
+13 ;;^UTILITY(U,$J,358.3,19080,2)
+14 ;;=^5003375
+15 ;;^UTILITY(U,$J,358.3,19081,0)
+16 ;;=F17.201^^64^848^12
+17 ;;^UTILITY(U,$J,358.3,19081,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,19081,1,3,0)
+20 ;;=3^Nicotine Dependence,Unspec,In Remission
+21 ;;^UTILITY(U,$J,358.3,19081,1,4,0)
+22 ;;=4^F17.201
+23 ;;^UTILITY(U,$J,358.3,19081,2)
+24 ;;=^5003361
+25 ;;^UTILITY(U,$J,358.3,19082,0)
+26 ;;=F17.200^^64^848^13
+27 ;;^UTILITY(U,$J,358.3,19082,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,19082,1,3,0)
+30 ;;=3^Nicotine Dependence,Unspec,Uncomplicated
+31 ;;^UTILITY(U,$J,358.3,19082,1,4,0)
+32 ;;=4^F17.200
+33 ;;^UTILITY(U,$J,358.3,19082,2)
+34 ;;=^5003360
+35 ;;^UTILITY(U,$J,358.3,19083,0)
+36 ;;=F19.20^^64^848^17
+37 ;;^UTILITY(U,$J,358.3,19083,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,19083,1,3,0)
+40 ;;=3^Psycoactive Substance Dependence,Uncomplicated
+41 ;;^UTILITY(U,$J,358.3,19083,1,4,0)
+42 ;;=4^F19.20
+43 ;;^UTILITY(U,$J,358.3,19083,2)
+44 ;;=^5003431
+45 ;;^UTILITY(U,$J,358.3,19084,0)
+46 ;;=F43.11^^64^848^14
+47 ;;^UTILITY(U,$J,358.3,19084,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,19084,1,3,0)
+50 ;;=3^PTSD,Acute
+51 ;;^UTILITY(U,$J,358.3,19084,1,4,0)
+52 ;;=4^F43.11
+53 ;;^UTILITY(U,$J,358.3,19084,2)
+54 ;;=^5003571
+55 ;;^UTILITY(U,$J,358.3,19085,0)
+56 ;;=F43.12^^64^848^15
+57 ;;^UTILITY(U,$J,358.3,19085,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,19085,1,3,0)
+60 ;;=3^PTSD,Chronic
+61 ;;^UTILITY(U,$J,358.3,19085,1,4,0)
+62 ;;=4^F43.12
+63 ;;^UTILITY(U,$J,358.3,19085,2)
+64 ;;=^5003572
+65 ;;^UTILITY(U,$J,358.3,19086,0)
+66 ;;=F43.10^^64^848^16
+67 ;;^UTILITY(U,$J,358.3,19086,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,19086,1,3,0)
+70 ;;=3^PTSD,Unspec
+71 ;;^UTILITY(U,$J,358.3,19086,1,4,0)
+72 ;;=4^F43.10
+73 ;;^UTILITY(U,$J,358.3,19086,2)
+74 ;;=^5003570
+75 ;;^UTILITY(U,$J,358.3,19087,0)
+76 ;;=Z87.891^^64^848^4
+77 ;;^UTILITY(U,$J,358.3,19087,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,19087,1,3,0)
+80 ;;=3^Hx of Nicotine Dependence
+81 ;;^UTILITY(U,$J,358.3,19087,1,4,0)
+82 ;;=4^Z87.891
+83 ;;^UTILITY(U,$J,358.3,19087,2)
+84 ;;=^5063518
+85 ;;^UTILITY(U,$J,358.3,19088,0)
+86 ;;=F32.A^^64^848^3
+87 ;;^UTILITY(U,$J,358.3,19088,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,19088,1,3,0)
+90 ;;=3^Depression,Unspec
+91 ;;^UTILITY(U,$J,358.3,19088,1,4,0)
+92 ;;=4^F32.A
+93 ;;^UTILITY(U,$J,358.3,19088,2)
+94 ;;=^5161153
+95 ;;^UTILITY(U,$J,358.3,19089,0)
+96 ;;=L40.2^^64^849^1
+97 ;;^UTILITY(U,$J,358.3,19089,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,19089,1,3,0)
+100 ;;=3^Acrodermatitis Continua
+101 ;;^UTILITY(U,$J,358.3,19089,1,4,0)
+102 ;;=4^L40.2
+103 ;;^UTILITY(U,$J,358.3,19089,2)
+104 ;;=^5009162
+105 ;;^UTILITY(U,$J,358.3,19090,0)
+106 ;;=L03.91^^64^849^2
+107 ;;^UTILITY(U,$J,358.3,19090,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,19090,1,3,0)
+110 ;;=3^Acute Lymphangitis,Unspec
+111 ;;^UTILITY(U,$J,358.3,19090,1,4,0)
+112 ;;=4^L03.91
+113 ;;^UTILITY(U,$J,358.3,19090,2)
+114 ;;=^5009068
+115 ;;^UTILITY(U,$J,358.3,19091,0)
+116 ;;=L23.9^^64^849^3
+117 ;;^UTILITY(U,$J,358.3,19091,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,19091,1,3,0)
+120 ;;=3^Allergic Contact Dermatitis
+121 ;;^UTILITY(U,$J,358.3,19091,1,4,0)
+122 ;;=4^L23.9
+123 ;;^UTILITY(U,$J,358.3,19091,2)
+124 ;;=^5009125
+125 ;;^UTILITY(U,$J,358.3,19092,0)
+126 ;;=L03.90^^64^849^4
